BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19361515)

  • 1. Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design.
    Immormino RM; Metzger LE; Reardon PN; Dollins DE; Blagg BS; Gewirth DT
    J Mol Biol; 2009 May; 388(5):1033-42. PubMed ID: 19361515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.
    Schulte TW; Akinaga S; Murakata T; Agatsuma T; Sugimoto S; Nakano H; Lee YS; Simen BB; Argon Y; Felts S; Toft DO; Neckers LM; Sharma SV
    Mol Endocrinol; 1999 Sep; 13(9):1435-48. PubMed ID: 10478836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. II. Ligand-mediated activation of GRP94 molecular chaperone and peptide binding activity.
    Wassenberg JJ; Reed RC; Nicchitta CV
    J Biol Chem; 2000 Jul; 275(30):22806-14. PubMed ID: 10816560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATPase cycle of the endoplasmic chaperone Grp94.
    Frey S; Leskovar A; Reinstein J; Buchner J
    J Biol Chem; 2007 Dec; 282(49):35612-20. PubMed ID: 17925398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin.
    Hadden MK; Blagg BS
    J Org Chem; 2009 Jul; 74(13):4697-704. PubMed ID: 19492825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone.
    Immormino RM; Dollins DE; Shaffer PL; Soldano KL; Walker MA; Gewirth DT
    J Biol Chem; 2004 Oct; 279(44):46162-71. PubMed ID: 15292259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding.
    Que NLS; Crowley VM; Duerfeldt AS; Zhao J; Kent CN; Blagg BSJ; Gewirth DT
    J Med Chem; 2018 Apr; 61(7):2793-2805. PubMed ID: 29528635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of GRP94-nucleotide complexes reveal mechanistic differences between the hsp90 chaperones.
    Dollins DE; Warren JJ; Immormino RM; Gewirth DT
    Mol Cell; 2007 Oct; 28(1):41-56. PubMed ID: 17936703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship among ligand conformations in solution, in the solid state, and at the Hsp90 binding site: geldanamycin and radicicol.
    Thepchatri P; Eliseo T; Cicero DO; Myles D; Snyder JP
    J Am Chem Soc; 2007 Mar; 129(11):3127-34. PubMed ID: 17323946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90.
    Xu W; Mimnaugh E; Rosser MF; Nicchitta C; Marcu M; Yarden Y; Neckers L
    J Biol Chem; 2001 Feb; 276(5):3702-8. PubMed ID: 11071886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90.
    Huck JD; Que NLS; Immormino RM; Shrestha L; Taldone T; Chiosis G; Gewirth DT
    J Biol Chem; 2019 Nov; 294(44):16010-16019. PubMed ID: 31501246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel quaternary domain interactions in the Hsp90 chaperone, GRP94.
    Chu F; Maynard JC; Chiosis G; Nicchitta CV; Burlingame AL
    Protein Sci; 2006 Jun; 15(6):1260-9. PubMed ID: 16731965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Functional Complementation between Grp94 and Hsp90.
    Maharaj KA; Que NL; Hong F; Huck JD; Gill SK; Wu S; Li Z; Gewirth DT
    PLoS One; 2016; 11(11):e0166271. PubMed ID: 27824935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding.
    Rosser MF; Nicchitta CV
    J Biol Chem; 2000 Jul; 275(30):22798-805. PubMed ID: 10816561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90.
    Shen G; Wang M; Welch TR; Blagg BS
    J Org Chem; 2006 Sep; 71(20):7618-31. PubMed ID: 16995666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation.
    Soldano KL; Jivan A; Nicchitta CV; Gewirth DT
    J Biol Chem; 2003 Nov; 278(48):48330-8. PubMed ID: 12970348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of radamide analogs as Grp94 inhibitors.
    Muth A; Crowley V; Khandelwal A; Mishra S; Zhao J; Hall J; Blagg BS
    Bioorg Med Chem; 2014 Aug; 22(15):4083-98. PubMed ID: 25027801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on the microbes that produce heat shock protein 90-targeting antibiotics.
    Piper PW; Millson SH
    Open Biol; 2012 Dec; 2(12):120138. PubMed ID: 23271830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organelle-specific Hsp90 inhibitors.
    Seo YH
    Arch Pharm Res; 2015 Sep; 38(9):1582-90. PubMed ID: 26195286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrating for resistance to radicicol.
    Duerfeldt AS; Blagg BS
    ACS Chem Biol; 2009 Apr; 4(4):245-7. PubMed ID: 19371133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.